Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension
Risk stratification refinements with inclusion of hemodynamic variables at follow-up in patients with pulmonary arterial hypertension
Updates on Pulmonary Hypertension Clinical Trials
Updates on Pulmonary Hypertension Clinical Trials
PH Management Into the Future: Understanding the Next Generation of Treatments and Mechanisms
PH Management Into the Future: Understanding the Next Generation of Treatments and Mechanisms
Practical Implications of New Treatments in Clinical Practice
Practical Implications of New Treatments in Clinical Practice
Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type
Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type
Don’t Wait to Escalate—Getting Aggressive in PH Management
Don’t Wait to Escalate—Getting Aggressive in PH Management
Recommendations on the management of HCM in guidelines: European vs. American views
Recommendations on the management of HCM in guidelines: European vs. American views
Evaluation of the complex cardiac pathophysiology in HCM
Evaluation of the complex cardiac pathophysiology in HCM
Myosin inhibitors: recent clinical data and applications in HCM and HF
Myosin inhibitors: recent clinical data and applications in HCM and HF
Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy
Challenges of managing hyperkalemia in patients with cardiorenal disease while maintaining RAASi therapy
